Browse articles from EyeWorld.org related to pain. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Topline results from trial for biologic eye drop for dry eye ➤ First patient dosed in Phase 3 trial evaluating oral non-opioid sedation ➤ First patient dosed in retinitis pigmentosa gene therapy trial ➤ Clinical program for IOP-lowering drug discontinued ➤ ASCRS news and events
➤ Phase 3 results for new corticosteroid ➤ Positive topline results from Phase 3 trials investigating presbyopia drop ➤ Phase 2 data presented for IOP-lowering intracameral implant ➤ First patient dosed in retinitis pigmentosa gene therapy ➤ Survey shows burden of pterygium ➤ ASCRS news and events
➤ FDA approves new drug for postop inflammation and pain ➤ Primary endpoints in unadjusted population not met in Phase 3 trial for dry eye drop ➤ Study links inherited eye diseases to gut bacteria ➤ Acquisitions and other news ➤ ASCRS news and events
➤ FDA approves IND for neuropathic pain drug ➤ Phase 2 preliminary efficacy and safety data for wet AMD treatment trial ➤ First-in-human data for DME, AMD therapy ➤ Study: Rapid eye stroke detection protocol helps prevent vision loss ➤ Enrollment complete for Phase 3 trial for sozinibercept ➤ ASCRS news and events
➤ FDA warns against copycat eye drops ➤ Generic drop receives FDA approval ➤ Topline data revealed in two presentations ➤ New 72-week data from Phase 3 RVO treatment studies ➤ First patient dosed in Phase 2/3 trial for GA treatment ➤ ASCRS news and events
➤ Positive Phase 3 results in trial investigating topical diabetic macular edema treatment ➤ Positive topline results in Phase 3 trials for retinal vein occlusion treatment ➤ IND filed for drug to treat neuropathic corneal pain ➤ Trial for ‘first-in-class anti-VEGF-complement dual targeting drug’ begins dosing patients ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ First implantations for clinical trials for investigational IOLs ➤ Phase 2 clinical trial for wet AMD treatment completes enrollment ➤ Two-year results from trial showcase vision gains in wet AMD at extended aflibercept dosing intervals ➤ Acquisition update ➤ ASCRS news and events
➤ Positive Phase 3 results from trial investigating ocular pain, inflammation treatment ➤ Study evaluates use of sustained-release drug during Medicare pass-through program ➤ FDA approves treatment for geographic atrophy ➤ Dementia ‘much higher’ in patients with visual problems ➤ ASCRS news and events
➤ CDC reports cases of ocular monkeypox ➤ Recall of intravitreal implant ➤ NDA filed for nanoemulsion for postop inflammation and pain ➤ Companies partner to enhance visual assessment technology ➤ Companies enter into business combination agreement ➤ ASCRS news and events
➤ Phase 3 trial investigating inflammation, pain management after cataract surgery ➤ Positive topline data in study for RP gene therapy ➤ Study: Intravitreal cancer drug found to preserve vision more than traditional therapy ➤ Several studies show efficacy of home-based OCT ➤ Company announces expense reduction and refocus plan ➤ ASCRS news and events